OHMX. bio is a Belgian brand founded in 2019 as a spin-off initiative of Ghent University. They offer innovative OMICS solutions to help researchers in the global research community answer their biological questions using cutting-edge technology.

With a complete R&D platform, OHMX. bio provides start-to-finish project management, from sample preparation to customized data analysis and reporting, in the fields of transcriptomics, translatomics, proteomics, and (epi)genetics. They specialize in measuring different -omics levels and their modifications, including DNA/RNA epigenetics and post-translational modifications.

OHMX. bio utilizes state-of-the-art sequencing technologies from Illumina and Oxford Nanopore to provide genome-wide maps for their customers. Their expertise currently lies in ribosome profiling or RIBO-seq, but they are constantly expanding their service portfolio to include new technologies, such as direct DNA and RNA sequencing and single-cell transcriptomics.

With an experienced team of wet-lab scientists, bioinformaticians, and complementary experts, OHMX. bio is dedicated to delivering superior quality multi-omics research services on demand